Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Davis To Shepherd Merck & Co. Toward The Post-Keytruda Era, As Frazier Exits
Feb 04 2021
•
By
Jessica Merrill
Merck's incoming CEO Robert Davis with Ken Frazier • Source: Merck & Co.
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Leadership
More from Scrip